表紙
市場調查報告書

急性缺血性腦中風:流行病學的預測

Acute Ischemic Stroke: Epidemiology Forecast to 2027

出版商 GlobalData 商品編碼 692854
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
急性缺血性腦中風:流行病學的預測 Acute Ischemic Stroke: Epidemiology Forecast to 2027
出版日期: 2018年07月31日內容資訊: 英文 50 Pages
簡介

在 (美國、德國、法國、義大利、西班牙、英國、日本、中國 (都市區)) 中,最初接受了急性缺血性腦中風 (AIS)的診斷全球主要8個國家的患者人數,2017年是257萬0175人,預計2027年達370萬8465人,以年度平均4.43%的速度增加。還有AIS診斷的受診者總數,估計2017年達到1796萬8771人,2027年達2293萬1332人。

本報告提供全球主要8個國家急性缺血性腦中風 (AIS)的發病情形與今後預測相關分析,疾病的特徵,及目前患病者的總數與趨勢 (年齡、男女趨勢,病期分類 (TOAST),受診趨勢等),今後10年的趨勢預測等調查。

第1章 目錄

第2章 急性缺血性腦中風:摘要整理

第3章 流行病學

  • 疾病的背景情況
  • 風險要素和共生病症
  • 過去的全球趨勢
  • 預測手法
    • 資訊來源
    • 預測的前提條件、手法
  • 急性缺血性腦中風 (AIS)的流行病學的預測 (總計11年份)
    • AIS的初期受診者數
    • AIS的初期受診者數:各年齡層
    • AIS的初期受診者數:男女
    • 復發性AIS的受診者數
    • AIS診斷的初期受診者數:TOAST各分類
    • AIS的已受診患者數
    • AIS的已受診患者數:各年齡層
    • AIS的已受診患者數:男女
    • AIS的死亡率
  • 討論
    • 流行病學性的預測結果相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

目錄
Product Code: GDHCER191-18

Acute Ischemic Stroke (AIS) occurs due to an obstructed blood vessel that supplies blood to the brain, and is the predominant type of stroke, accounting for approximately 65-90% of stroke cases across the US, Europe, and Asia. The major risk factors associated with the development of Acute Ischemic Stroke (AIS) include both modifiable and non-modifiable conditions, such as hypertension, smoking, diabetes mellitus, obesity, age, and family history of stroke.

Epidemiologists forecast that the first-ever diagnosed incident cases of Acute Ischemic Stroke (AIS) in the 8MM will grow by an annual growth rate (AGR) of 4.43%, from 2,570,175 cases in 2017 to 3,708,465 cases in 2027. In the 8MM in 2017, urban China had the highest number of first-ever diagnosed incident cases with 1,735,727, while the UK had the lowest number of first-ever diagnosed incident cases with 50,803.

Additionally, epidemiologists forecast that the diagnosed prevalent cases of Acute Ischemic Stroke (AIS) in the 8MM will grow by an AGR of 2.76%, from 17,968,771 cases in 2017 to 22,931,332 cases in 2027. In the 8MM in 2017, the US had the highest number of diagnosed prevalent cases with 6,760,839, while Spain had the lowest number of diagnosed prevalent cases with 346,779.

The report "Acute Ischemic Stroke: Epidemiology Forecast to 2027", provides an overview of the risk factors, comorbidities, and global and historical trends for AIS in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). It includes a 10-year epidemiological forecast for first-ever diagnosed incident cases of AIS, diagnosed prevalent cases of AIS, and mortality of AIS. First-ever diagnosed incident cases are further segmented by age (18 to 85 years and older), sex, recurrence, and Trial of Org 10172 in Acute Stroke Treatment (TOAST) subtype (large-artery atherosclerosis, cardioembolism, small-artery occlusion, other determined cause, undetermined cause [cryptogenic]), while diagnosed prevalent cases are further segmented by age (18 to 85 years and older) and sex.

Scope

  • The Acute Ischemic Stroke (AIS) Epidemiology Forecast Report provides an overview of the risk factors and global trends of AIS in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China).
  • This report also includes a 10-year epidemiological forecast for first-ever diagnosed incident cases of AIS, diagnosed prevalent cases of AIS, and mortality of AIS. First-ever diagnosed incident cases are further segmented by age (18 to 85 years and older), sex, recurrence, and Trial of Org 10172 in Acute Stroke Treatment (TOAST) subtype (large-artery atherosclerosis, cardioembolism, small-artery occlusion, other determined cause, undetermined cause [cryptogenic]), while diagnosed prevalent cases are further segmented by age (18 to 85 years and older) and sex.
  • The Acute Ischemic Stroke epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Acute Ischemic Stroke (AIS) Epidemiology Forecast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global AIS market.
  • Quantify patient populations in the global AIS market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AIS therapeutics in each of the markets covered.
  • Understand magnitude of AIS population by recurrence, subtype, and mortality.

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Acute Ischemic Stroke: Executive Summary 4

  • 2.1 Related Reports 6
  • 2.2 Upcoming Reports 7

3 Epidemiology 8

  • 3.1 Disease Background 8
  • 3.2 Risk Factors and Comorbidities 8
  • 3.3 Global and Historical Trends 10
  • 3.4 Forecast Methodology 14
    • 3.4.1 Sources 15
    • 3.4.2 Forecast Assumptions and Methods 19
  • 3.5 Epidemiological Forecast for AIS (2017-2027) 31
    • 3.5.1 First-Ever Diagnosed Incident Cases of AIS 31
    • 3.5.2 Age-Specific First-Ever Diagnosed Incident Cases of AIS 32
    • 3.5.3 Sex-Specific First-Ever Diagnosed Incident Cases of AIS 34
    • 3.5.4 Recurrent Diagnosed Incident Cases of AIS 35
    • 3.5.5 First-Ever Diagnosed Incident Cases of AIS by TOAST Subtype 36
    • 3.5.6 Diagnosed Prevalent Cases of AIS 37
    • 3.5.7 Age-Specific Diagnosed Prevalent Cases of AIS 38
    • 3.5.8 Sex-Specific Diagnosed Prevalent Cases of AIS 39
    • 3.5.9 AIS Mortality 40
  • 3.6 Discussion 41
    • 3.6.1 Epidemiological Forecast Insight 41
    • 3.6.2 Limitations of Analysis 41
    • 3.6.3 Strengths of Analysis 42

4 Appendix 43

  • 4.1 Bibliography 43
  • 4.2 About the Authors 48
    • 4.2.1 Epidemiologist 48
    • 4.2.2 Reviewers 48
    • 4.2.3 Global Director of Therapy Analysis and Epidemiology 49
    • 4.2.4 Global Head and EVP of Healthcare Operations and Strategy 49
  • 4.3 About GlobalData 50
  • 4.4 Contact Us 50
  • 4.5 Disclaimer 50

1.1 List of Tables

  • Table 1: Risk Factors and Comorbidities for AIS 9

1.2 List of Figures

  • Figure 1: 8MM, Diagnosed Incident Cases of First-Ever AIS, Men and Women, Ages ≥18 Years, 2017 and 2027 5
  • Figure 2: 8MM, Diagnosed Prevalent Cases of AIS, Men and Women, Ages ≥18 Years, 2017 and 2027 6
  • Figure 3: 8MM, Age-Standardized First-Ever Diagnosed Incidence of AIS, Men, Ages ≥18 Years, 2007-2027 11
  • Figure 4: 8MM, Age-Standardized First-Ever Diagnosed Incidence of AIS, Women, Ages ≥18 Years, 2007-2027 12
  • Figure 5: 8MM, Age-Standardized Diagnosed Prevalence of AIS, Men, Ages ≥18 Years, 2007-2027 13
  • Figure 6: 8MM, Age-Standardized Diagnosed Prevalence of AIS, Women, Ages ≥18 Years, 2007-2027 13
  • Figure 7: Sources Used and Not Used for First-Ever Diagnosed Incident Cases of AIS 15
  • Figure 8: Sources Used and Not Used for Recurrent Diagnosed Incident Cases of AIS 16
  • Figure 9: Sources Used and Not Used for First-Ever Diagnosed Incident Cases of AIS by TOAST Subtype 17
  • Figure 10: Sources Used and Not Used for Diagnosed Prevalent Cases of AIS 18
  • Figure 11: Sources Used and Not Used for AIS Mortality 19
  • Figure 12: 8MM, First-Ever Diagnosed Incident Cases of AIS, Men and Women, Ages ≥18 Years, 2017 32
  • Figure 13: 8MM, Age-Specific First-Ever Diagnosed Incident Cases of AIS, Men and Women, 2017 33
  • Figure 14: 8MM, Sex-Specific First-Ever Diagnosed Incident Cases of AIS, Ages ≥18 Years, 2017 34
  • Figure 15: 8MM, Recurrent Diagnosed Incident Cases of AIS, Ages ≥18 Years, Men and Women, 2017 35
  • Figure 16: 8MM, First-Ever Diagnosed Incident Cases of AIS by TOAST Subtype, Ages ≥18 Years, Men and Women, 2017 36
  • Figure 17: 8MM, Diagnosed Prevalent Cases of AIS, Men and Women, Ages ≥18 Years, 2017 37
  • Figure 18: 8MM, Age-Specific Diagnosed Prevalent Cases of AIS, Men and Women, 2017 38
  • Figure 19: 8MM, Sex-Specific Diagnosed Prevalent Cases of AIS, Ages ≥18 Years, 2017 39
  • Figure 20: 8MM, AIS Mortality, Ages ≥18 Years, Men and Women, 2017 40